DWJ1252 clinical trials
Also written DWJ1252.
How each study uses DWJ1252 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- DWJ1252
- 3
Studies by the year they started
3 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2016 | 1 |
| 2017 | 1 |
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses DWJ1252 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Efficacy and Safety of DWJ1252 in the Treatment of Functional DyspepsiaCompletedPhase 3Daewoong Pharmaceutical Co. LTD.NCT03024086Written as DWJ1252
- Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)CompletedPhase 3Daewoong Pharmaceutical Co. LTD.NCT03184402Written as DWJ1252
- Clinical Trials to Compare Mosapride Bioavailability Between DWJ1252 and Mosapride MedicineCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT01094847Written as DWJ1252